Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions

Jürgen Pannek, Jens Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland Introduction: Urinary tract infections (UTIs) are one of the most common morbidities in persons with neurogenic lower urinary tract dysfunction (NLUTD). They are associated with a sign...

Full description

Bibliographic Details
Main Authors: Pannek J, Wöllner J
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Research and Reports in Urology
Subjects:
Online Access:https://www.dovepress.com/management-of-urinary-tract-infections-in-patients-with-neurogenic-bla-peer-reviewed-article-RRU
id doaj-997b94731ca84a7797abda8344dc4b02
record_format Article
spelling doaj-997b94731ca84a7797abda8344dc4b022020-11-24T21:29:59ZengDove Medical PressResearch and Reports in Urology2253-24472017-07-01Volume 912112733705Management of urinary tract infections in patients with neurogenic bladder: challenges and solutionsPannek JWöllner JJürgen Pannek, Jens Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland Introduction: Urinary tract infections (UTIs) are one of the most common morbidities in persons with neurogenic lower urinary tract dysfunction (NLUTD). They are associated with a significant morbidity and mortality, and they affect the quality of life of the affected patients. Diagnosis and treatment of UTI in this group of patients are challenging. In this review, the current strategies regarding diagnosis, treatment, and prevention are summarized. Diagnostics: it is important to correctly diagnose a UTI, as treatment of bacteriuria should strictly be avoided. A UTI is defined as a combination of laboratory findings (leukocyturia and bacteriuria) and symptoms. Laboratory findings without symptoms are classified as asymptomatic bacteriuria. Routine urine screening is not advised. Treatment: Only UTI should be treated; treatment of asymptomatic bacteriuria is not indicated. Prior to treatment, urine for a urine culture should be obtained. Antibiotic treatment for ~7 days is advised. Prevention: In recurrent UTI, bladder management should be optimized and morphologic causes for UTI should be excluded. If UTIs persist, medical prophylaxis should be considered. Currently, no prophylactic measure with evidence-based efficacy exists. Long-term antibiotic prophylaxis should be used merely as an ultimate measure. Among the various mentioned innovative approaches for UTI prevention, bacteriophages, intravesical instillations, complementary and alternative medicine techniques, and probiotics seem to be most promising. Conclusion: Recently, several promising innovative options for UTI prophylaxis have been developed which may help overcome the current therapeutic dilemma. However, further well designed studies are necessary to evaluate the safety and efficacy of these approaches. Keywords: neurogenic lower urinary tract dysfunction, spinal cord injury, prophylaxis, resistance, lactobacilli, cranberrieshttps://www.dovepress.com/management-of-urinary-tract-infections-in-patients-with-neurogenic-bla-peer-reviewed-article-RRUneurogenic lower urinary tract dysfunctionurinary tract infectionprophylaxisspinal cord injury
collection DOAJ
language English
format Article
sources DOAJ
author Pannek J
Wöllner J
spellingShingle Pannek J
Wöllner J
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
Research and Reports in Urology
neurogenic lower urinary tract dysfunction
urinary tract infection
prophylaxis
spinal cord injury
author_facet Pannek J
Wöllner J
author_sort Pannek J
title Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
title_short Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
title_full Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
title_fullStr Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
title_full_unstemmed Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
title_sort management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
publisher Dove Medical Press
series Research and Reports in Urology
issn 2253-2447
publishDate 2017-07-01
description Jürgen Pannek, Jens Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland Introduction: Urinary tract infections (UTIs) are one of the most common morbidities in persons with neurogenic lower urinary tract dysfunction (NLUTD). They are associated with a significant morbidity and mortality, and they affect the quality of life of the affected patients. Diagnosis and treatment of UTI in this group of patients are challenging. In this review, the current strategies regarding diagnosis, treatment, and prevention are summarized. Diagnostics: it is important to correctly diagnose a UTI, as treatment of bacteriuria should strictly be avoided. A UTI is defined as a combination of laboratory findings (leukocyturia and bacteriuria) and symptoms. Laboratory findings without symptoms are classified as asymptomatic bacteriuria. Routine urine screening is not advised. Treatment: Only UTI should be treated; treatment of asymptomatic bacteriuria is not indicated. Prior to treatment, urine for a urine culture should be obtained. Antibiotic treatment for ~7 days is advised. Prevention: In recurrent UTI, bladder management should be optimized and morphologic causes for UTI should be excluded. If UTIs persist, medical prophylaxis should be considered. Currently, no prophylactic measure with evidence-based efficacy exists. Long-term antibiotic prophylaxis should be used merely as an ultimate measure. Among the various mentioned innovative approaches for UTI prevention, bacteriophages, intravesical instillations, complementary and alternative medicine techniques, and probiotics seem to be most promising. Conclusion: Recently, several promising innovative options for UTI prophylaxis have been developed which may help overcome the current therapeutic dilemma. However, further well designed studies are necessary to evaluate the safety and efficacy of these approaches. Keywords: neurogenic lower urinary tract dysfunction, spinal cord injury, prophylaxis, resistance, lactobacilli, cranberries
topic neurogenic lower urinary tract dysfunction
urinary tract infection
prophylaxis
spinal cord injury
url https://www.dovepress.com/management-of-urinary-tract-infections-in-patients-with-neurogenic-bla-peer-reviewed-article-RRU
work_keys_str_mv AT pannekj managementofurinarytractinfectionsinpatientswithneurogenicbladderchallengesandsolutions
AT wollnerj managementofurinarytractinfectionsinpatientswithneurogenicbladderchallengesandsolutions
_version_ 1725964710759628800